John R. Horn, PharmD, FCCP and Philip D. Hansten, PharmD
References
1. de Abajo FJ, Garcia-Rodriguez LA, Monero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999;319:1106-9.
2. de Abajo FJ, Garcia-Rodriguez LA. Risk
of upper gastrointestinal tract bleeding associated with selective serotonin
reuptake inhibitors and venlafaxine therapy. Arch Gen Psychiatry. 2008;65:795-803.
3. Masclee GM, Valkhoff VE, Coloma PM, et al.
Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology. 2014;147:784-92.
4. Vitry AI, Roughead EE, Ramsay EN et al. Major
bleeding risk associated with warfarin and co-medications in the elderly
population. Pharmacoepidemiol Drug Saf.
2011;20:1057-63.
5. Loke YK, Trivedi AN, Singh S. Meta-analysis:
gastrointestinal bleeding due to interaction between selective serotonin uptake
inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008;27:31–40.
6. Schalekamp T, Klungel OH, Souverein PC et al. Increased
bleeding risk with concurrent use of selective serotonin reuptake inhibitors
and coumarins. Arch Intern Med.
2008;168:180-5.
7. Cochran
KA, Cavallari LH, Shapiro NL et al. Bleeding Incidence With Concomitant Use of Antidepressants
and Warfarin. Ther Drug Monit. 2011;33:433–8.